Laurel Wealth Planning LLC

EDINA, MN · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 2, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$230.3M2026 Q3
Positions70
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.43.5%

Laurel Wealth Planning LLC reported 70 positions worth $230.3M as of September 30, 2026 (13F filed November 2, 2026). Largest holding: VOO (7.2%). Biggest move: new buy DFEV ($7.0M).

10 / 70 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 VOOVanguard Index FDS$16.6M7.21%23,705——-2.9%
▸ 2 ESGUIshares Tr$12.1M5.26%72,662———
▸ 3 EFIVSPDR Series$10.3M4.47%139,141———
▸ 4 IFRAIshares Tr$10.2M4.43%185,187———
▸ 5 DFIVDimensional ETF$9.9M4.30%177,390———
▸ 6 NULGNushares ETF Tr$9.5M4.13%83,564———
▸ 7 ESGDIshares Tr$9.2M3.99%89,059———
▸ 8 LVHILegg Mason ETF$7.9M3.43%189,142———
▸ 9 SPYVSPDR Series$7.5M3.27%123,280———
▸ 10 DFEVDimensional ETF$7.0M3.04%165,338———

Pro Feature

The remaining 60 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Laurel Wealth Planning LLC hold as of Q3 2026?

Laurel Wealth Planning LLC reported 70 positions worth $230.3M in its Q3 2026 13F filing. Largest positions: VOO (7.2%), ESGU (5.3%), EFIV (4.5%), IFRA (4.4%) and DFIV (4.3%).

What did Laurel Wealth Planning LLC buy in Q3 2026?

New positions: DFEV, JPIB, USTB, VFLO and WCPB. Added to: ESGU, CGMM, EMNT, IFRA and DFSI (11 in all).

What did Laurel Wealth Planning LLC sell in Q3 2026?

Reduced: EFIV, VOO, INDA, ADM and NULG (32 in all). Sold out entirely: EPI and NOBL.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.